AptaBio Therapeutics (Korea) Price History

293780 Stock   6,280  80.00  1.26%   
If you're considering investing in AptaBio Stock, it is important to understand the factors that can impact its price. As of today, the current price of AptaBio Therapeutics stands at 6,280, as last reported on the 22nd of November, with the highest price reaching 6,440 and the lowest price hitting 6,250 during the day. AptaBio Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0965, which signifies that the company had a -0.0965% return per unit of risk over the last 3 months. AptaBio Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AptaBio Therapeutics' Risk Adjusted Performance of (0.08), standard deviation of 4.1, and Mean Deviation of 3.03 to double-check the risk estimate we provide.
  
AptaBio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0965

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns293780

Estimated Market Risk

 4.14
  actual daily
36
64% of assets are more volatile

Expected Return

 -0.4
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average AptaBio Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AptaBio Therapeutics by adding AptaBio Therapeutics to a well-diversified portfolio.

AptaBio Therapeutics Stock Price History Chart

There are several ways to analyze AptaBio Stock price data. The simplest method is using a basic AptaBio candlestick price chart, which shows AptaBio Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 4, 202410150.0
Lowest PriceNovember 19, 20246230.0

AptaBio Therapeutics November 22, 2024 Stock Price Synopsis

Various analyses of AptaBio Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell AptaBio Stock. It can be used to describe the percentage change in the price of AptaBio Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of AptaBio Stock.
AptaBio Therapeutics Price Daily Balance Of Power(0.42)
AptaBio Therapeutics Accumulation Distribution 2,279 
AptaBio Therapeutics Price Rate Of Daily Change 0.99 
AptaBio Therapeutics Price Action Indicator(105.00)
AptaBio Therapeutics Market Facilitation Index 0 

AptaBio Therapeutics November 22, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in AptaBio Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use AptaBio Therapeutics intraday prices and daily technical indicators to check the level of noise trading in AptaBio Stock and then apply it to test your longer-term investment strategies against AptaBio.

AptaBio Stock Price History Data

The price series of AptaBio Therapeutics for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 3920.0 with a coefficient of variation of 11.52. The prices are distributed with arithmetic mean of 8193.33. The median price for the last 90 days is 8200.0. The company had 2:1 stock split on 24th of August 2021.
OpenHighLowCloseVolume
11/22/2024 6,370  6,440  6,250  6,280  77,236 
11/21/2024 6,570  6,580  6,250  6,360  57,114 
11/20/2024 6,250  6,870  6,170  6,580  128,695 
11/19/2024 6,280  6,470  6,220  6,230  69,123 
11/18/2024 6,310  6,450  6,210  6,340  79,018 
11/15/2024 6,390  6,680  6,140  6,310  78,506 
11/14/2024 6,450  6,680  6,350  6,410  53,568 
11/13/2024 6,640  6,780  6,390  6,400  93,578 
11/12/2024 7,000  7,030  6,310  6,650  129,077 
11/11/2024 7,240  7,240  6,850  6,950  131,291 
11/08/2024 7,180  7,440  7,080  7,230  175,524 
11/07/2024 7,630  7,740  7,180  7,180  139,391 
11/06/2024 7,800  7,890  7,600  7,610  84,295 
11/05/2024 7,860  7,940  7,740  7,800  52,392 
11/04/2024 7,950  8,010  7,710  7,860  54,491 
11/01/2024 7,980  8,120  7,810  7,810  62,245 
10/31/2024 8,140  8,190  8,000  8,110  40,316 
10/30/2024 8,380  8,470  7,950  8,200  130,251 
10/29/2024 7,980  8,510  7,900  8,380  157,401 
10/28/2024 8,140  8,410  7,910  7,980  124,582 
10/25/2024 7,910  8,520  7,910  8,200  128,023 
10/24/2024 8,000  8,230  7,510  7,920  86,109 
10/23/2024 9,230  9,590  8,040  8,050  427,416 
10/22/2024 8,880  9,020  8,750  8,750  83,540 
10/21/2024 8,910  9,230  8,850  8,930  127,679 
10/18/2024 9,150  9,340  8,700  9,080  180,910 
10/17/2024 9,100  9,650  8,940  9,250  251,012 
10/16/2024 9,440  9,440  8,950  9,180  191,202 
10/15/2024 8,470  9,440  8,210  9,350  532,713 
10/14/2024 8,630  8,760  8,320  8,360  101,689 
10/11/2024 8,180  8,600  7,990  8,530  306,767 
10/10/2024 8,290  8,340  8,130  8,180  82,182 
10/08/2024 7,880  8,250  7,880  8,200  105,230 
10/07/2024 7,650  8,410  7,560  7,940  417,500 
10/04/2024 7,590  7,870  7,590  7,620  55,594 
10/02/2024 7,840  7,960  7,520  7,620  85,879 
09/30/2024 7,950  8,040  7,870  7,890  53,596 
09/27/2024 8,220  8,220  7,840  7,900  105,979 
09/26/2024 7,980  8,220  7,980  8,150  82,484 
09/25/2024 8,050  8,140  7,950  7,950  94,848 
09/24/2024 8,090  8,220  7,980  8,040  136,095 
09/23/2024 8,390  8,480  8,040  8,090  160,881 
09/20/2024 8,950  9,000  8,280  8,350  448,123 
09/19/2024 8,590  9,070  8,590  8,980  116,048 
09/13/2024 8,980  9,140  8,550  8,590  223,258 
09/12/2024 8,290  10,180  8,290  9,070  1,054,424 
09/11/2024 8,250  8,670  8,190  8,220  126,330 
09/10/2024 8,310  8,820  8,090  8,230  209,511 
09/09/2024 8,650  8,760  8,220  8,360  235,822 
09/06/2024 9,570  9,660  8,880  8,880  144,677 
09/05/2024 10,210  10,380  9,500  9,570  270,837 
09/04/2024 9,260  10,150  9,250  10,150  201,372 
09/03/2024 10,000  10,000  9,450  9,820  265,392 
09/02/2024 10,390  10,690  9,840  10,050  494,863 
08/30/2024 9,350  10,000  9,130  9,990  419,908 
08/29/2024 8,680  9,960  8,620  9,410  1,507,449 
08/28/2024 8,280  9,200  8,260  8,610  528,378 
08/27/2024 8,400  8,550  8,150  8,240  110,999 
08/26/2024 7,980  8,400  7,900  8,350  121,279 
08/23/2024 7,970  8,120  7,800  8,000  129,746 
08/22/2024 8,130  8,280  7,890  7,970  129,451 

About AptaBio Therapeutics Stock history

AptaBio Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AptaBio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AptaBio Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AptaBio Therapeutics stock prices may prove useful in developing a viable investing in AptaBio Therapeutics

AptaBio Therapeutics Stock Technical Analysis

AptaBio Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of AptaBio Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of AptaBio Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

AptaBio Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for AptaBio Therapeutics' price direction in advance. Along with the technical and fundamental analysis of AptaBio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AptaBio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for AptaBio Stock analysis

When running AptaBio Therapeutics' price analysis, check to measure AptaBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AptaBio Therapeutics is operating at the current time. Most of AptaBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of AptaBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AptaBio Therapeutics' price. Additionally, you may evaluate how the addition of AptaBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume